09/04/2024 4:34 PM | 10x Genomics (Issuer) Teichmann Sarah A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 4:03 PM | 10x Genomics (Issuer) 10x Genomics (Issuer) McAnear Justin J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 4:04 PM | 10x Genomics (Issuer) 10x Genomics (Issuer) Hindson Benjamin J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 4:05 PM | 10x Genomics (Issuer) 10x Genomics (Issuer) Saxonov Serge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 7:39 PM | 10x Genomics (Subject) Hindson Benjamin J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024 7:42 PM | 10x Genomics (Subject) McAnear Justin J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024 7:45 PM | 10x Genomics (Subject) Saxonov Serge (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/12/2024 10:16 AM | 10x Genomics (Subject) ARK Investment Management LLC (Filed by)
| Form SC 13G | |
07/19/2024 3:42 PM | 10x Genomics (Issuer) Teichmann Sarah A. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/26/2024 3:48 PM | 10x Genomics (Issuer) MATEO ALAN (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/13/2024 3:08 PM | 10x Genomics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 8:55 AM | 10x Genomics (Subject) BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
05/23/2024 6:52 PM | 10x Genomics (Issuer) Hindson Benjamin J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:53 PM | 10x Genomics (Issuer) Saxonov Serge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:54 PM | 10x Genomics (Issuer) McAnear Justin J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 3:23 PM | 10x Genomics (Subject) Saxonov Serge (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024 3:27 PM | 10x Genomics (Subject) Hindson Benjamin J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024 3:17 PM | 10x Genomics (Subject) McAnear Justin J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024 3:23 PM | 10x Genomics (Filer)
| Form PRE 14A | |
03/25/2024 4:15 PM | 10x Genomics (Issuer) McAnear Justin J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 4:16 PM | 10x Genomics (Issuer) Hindson Benjamin J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 4:17 PM | 10x Genomics (Issuer) Saxonov Serge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 6:02 PM | 10x Genomics (Issuer) Saxonov Serge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 5:40 PM | 10x Genomics (Subject) Saxonov Serge (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024 6:19 PM | 10x Genomics (Subject) Saxonov Serge (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024 5:59 PM | 10x Genomics (Subject) Hindson Benjamin J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024 6:06 PM | 10x Genomics (Subject) McAnear Justin J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 3:20 PM | 10x Genomics (Issuer) Saxonov Serge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:33 PM | 10x Genomics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/09/2024 7:35 AM | 10x Genomics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024 1:08 PM | 10x Genomics (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/29/2024 10:43 AM | 10x Genomics (Subject) BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
01/18/2024 3:49 PM | 10x Genomics (Issuer) Saxonov Serge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:08 PM | 10x Genomics (Subject) Saxonov Serge (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 8:00 AM | 10x Genomics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/29/2023 3:17 PM | 10x Genomics (Issuer) Saxonov Serge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 3:19 PM | 10x Genomics (Issuer) Hindson Benjamin J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 4:43 PM | 10x Genomics (Issuer) Saxonov Serge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 4:09 PM | 10x Genomics (Subject) Saxonov Serge (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023 3:37 PM | 10x Genomics (Subject) MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
11/27/2023 5:16 PM | 10x Genomics (Issuer) Hindson Benjamin J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
War on Elon Escalates… (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9244&Placement=NativeDisplay&Source=NativeDisplay) One company holds a near-total monopoly on it. |
11/27/2023 5:18 PM | 10x Genomics (Issuer) Wilbur James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 5:15 PM | 10x Genomics (Issuer) Saxonov Serge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 5:15 PM | 10x Genomics (Issuer) McAnear Justin J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 3:25 PM | 10x Genomics (Subject) Hindson Benjamin J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023 3:25 PM | 10x Genomics (Subject) McAnear Justin J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023 3:29 PM | 10x Genomics (Subject) Saxonov Serge (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023 3:30 PM | 10x Genomics (Issuer) Wilbur James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 5:08 PM | 10x Genomics (Subject) Wilbur James (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023 3:22 PM | 10x Genomics (Issuer) Saxonov Serge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 3:33 PM | 10x Genomics (Issuer) Saxonov Serge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 3:43 PM | 10x Genomics (Issuer) Saxonov Serge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/14/2023 4:15 PM | 10x Genomics (Subject) Saxonov Serge (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |